15 results on '"Grange, L."'
Search Results
2. Dysphagia in a patient with ankylosing spondylitis. Comment on « Esophagus type cervical spondylosis » by Ma et al. Joint Bone Spine 2019;86:643.
- Author
-
Fourcade G, Baillet A, Grange L, and Gastaldi R
- Subjects
- Cervical Vertebrae diagnostic imaging, Humans, Spine, Deglutition Disorders diagnosis, Deglutition Disorders etiology, Spondylitis, Ankylosing complications, Spondylitis, Ankylosing diagnostic imaging, Spondylosis complications, Spondylosis diagnostic imaging
- Published
- 2020
- Full Text
- View/download PDF
3. Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis.
- Author
-
Sellam J, Courties A, Eymard F, Ferrero S, Latourte A, Ornetti P, Bannwarth B, Baumann L, Berenbaum F, Chevalier X, Ea HK, Fabre MC, Forestier R, Grange L, Lellouche H, Maillet J, Mainard D, Perrot S, Rannou F, Rat AC, Roux CH, Senbel E, and Richette P
- Subjects
- Acetaminophen therapeutic use, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, France, Humans, Hyaluronic Acid therapeutic use, Injections, Intra-Articular, Osteoarthritis, Knee drug therapy, Rheumatology
- Abstract
Objectives: To establish recommendations for pharmacological treatment of knee osteoarthritis specific to France., Methods: On behalf of the French Society of Rheumatology (SFR), a bibliography group analyzed the literature on the efficacy and safety of each pharmacological treatment for knee osteoarthritis. This group joined a multidisciplinary working group to draw up recommendations. Strength of recommendation and quality of evidence level were assigned to each recommendation. A review committee gave its level of agreement., Results: Five general principles were established: 1) need to combine pharmacological and non-pharmacological treatments, 2) personalization of treatment, 3) symptomatic and/or functional aim of pharmacological treatments, 4) need to regularly re-assess the treatments and 5) discussion about arthroplasty if medical treatment fails. Six recommendations involved oral treatments: 1) paracetamol should not necessarily be prescribed systematically and/or continuously, 2) NSAIDs, possibly as first-line, 3) weak opioids, 4) strong opioids, 5) symptomatic slow-acting drugs of osteoarthritis, and 6) duloxetine (off-label use). Two recommendations involved topical agents (NSAIDs and capsaicin<1%). Three recommendations involved intra-articular treatments: corticosteroid or hyaluronic acid injections that can be proposed to patients. The experts did not draw a conclusion about the benefits of platelet-rich plasma injections., Conclusion: These are the first recommendations of the SFR on the pharmacological treatment of knee osteoarthritis., (Copyright © 2020 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
4. Real-world care for individuals aged over fifty with fractures in France: Evidence for a wide care gap-The EPIFRACT Study.
- Author
-
Briot K, Grange L, Cortet B, Feron JM, Chauvin P, Coulomb A, Alliot-Launois F, Sellami R, Touboul C, Perrin L, Joubert JM, and Launois R
- Subjects
- Adult, Aged, Emergency Service, Hospital, France epidemiology, Humans, Middle Aged, Vitamin D, Bone Density Conservation Agents therapeutic use, Fractures, Bone, Osteoporosis diagnostic imaging, Osteoporosis epidemiology, Osteoporotic Fractures diagnostic imaging, Osteoporotic Fractures epidemiology
- Abstract
Objectives: To describe the care trajectories of adults aged ≥50 years with fragility fractures in France., Methods: A postal questionnaire was sent to 15,000 individuals aged ≥50 years extracted from a representative panel of the French population (METASKOPE) in April-May 2018. Respondents experiencing a single fragility fracture in the previous three years constituted the study population. Information was collected regarding diagnosis, hospitalisations, physician visits and treatment related to the fractures., Results: 13,914 participants returned a questionnaire (92.8%), of whom 436 reported a single fragility fracture. Their mean age was 68.7±10.3 years. 11.9% of this sample had undergone bone densitometry (DXA) prior to the fracture and 11.9% had received a diagnostic of osteoporosis. Following the fracture, a further 17.4% underwent DXA and 8.5% were diagnosed with osteoporosis. 74.3% of fractures were initially managed in an emergency department and 29.6% led to immediate hospitalisation. Prior to fracture, 3.4% received a specific anti-osteoporotic treatment, 10.1% vitamin D and 6.4% calcium supplementation. After the fracture, these figures rose to 10.8%, 26.8% and 19.0% respectively. 86.2% participants made at least one follow-up visit to a physician., Conclusions: The rate of DXA screening following fragility fractures in subjects over fifty is very low. Most patients with fragility fractures did not receive a diagnosis of osteoporosis. The proportion of patients treated with a specific anti-osteoporotic treatment after a fracture is low even though around half consulted their general practitioner after the fracture. Practice guidelines are thus not being adhered to in everyday clinical practice in France., (Copyright © 2020. Published by Elsevier Masson SAS.)
- Published
- 2020
- Full Text
- View/download PDF
5. Self-reported competencies and educational needs of rheumatology nurses: Results of a national survey.
- Author
-
Beauvais C, Gossec L, Mulliez A, Fayet F, Poilverd RM, Pouplin S, Perrot S, L'amour C, Carton L, Aubert MP, Miconnet S, Grange L, Flipon-Cousin E, Mézieres M, Dougados M, Jaccaz-Vallée N, and Savel C
- Subjects
- Clinical Competence, Humans, Self Report, Surveys and Questionnaires, Nurses, Rheumatology
- Published
- 2020
- Full Text
- View/download PDF
6. Essential knowledge for patients with rheumatoid arthritis or spondyloarthritis: Results of a multicentric survey in France among health professionals and patients.
- Author
-
Beauvais C, Rodère M, Pereira B, Legoupil N, Piperno M, Pallot Prades B, Castaing P, Wendling D, Grange L, Costantino F, Carton L, Soubrier M, Coquerelle P, Pham T, Poivret D, Cohen JD, Tavares I, Nataf H, Pouplin S, Sordet C, and Gossec L
- Subjects
- Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Arthritis, Rheumatoid physiopathology, Delphi Technique, Female, France, Health Personnel, Humans, Male, Outcome Assessment, Health Care, Patient Education as Topic organization & administration, Self-Management, Spondylarthritis physiopathology, Antirheumatic Agents administration & dosage, Arthritis, Rheumatoid drug therapy, Health Knowledge, Attitudes, Practice, Pain Management methods, Spondylarthritis drug therapy, Surveys and Questionnaires
- Abstract
Objective: Information and education are recommended for patients with inflammatory arthritis including rheumatoid arthritis (RA) and spondyloarthritis (SpA). However, there is no consensus on which knowledge is essential to enhance patients' self-management. The aim of this study was to determine such knowledge., Methods: Based on published knowledge questionnaires (KQs) collected by a systematic literature review, a list of items was elaborated, classified in domains and sub domains. A Delphi process was performed with rheumatologists, healthcare professionals and patients in 2014-2015, selecting the items considered useful., Results: Three published KQs were analysed: 2 for RA; 1 for SpA and 5 unpublished KQs were collected. In the KQs, 90 knowledge items were mentioned for RA and 67 for SpA. The 1
st Delphi round enlarged the list to 322 items for RA and 265 items for SpA. The second round selected 69 and 59 knowledge items for RA and SpA respectively, of which 36 (52%) and 34 (57%) were not present or modified from the published KQs. Key domains included treatment strategies, managing cDMARDs and bDMARDs, managing symptomatic medications. Knowledge on non-pharmacological treatment concerned pain and fatigue, physical activity, adaptative skills to personal and professional environment, patient-HP communication and shared decision-making., Conclusion: The present study provides a corpus of knowledge considered essential for patients in the self-management of their arthritis. The selection of many items reflects recent emphasis on professional recommendations and the patients' perspective. Future work should lead to the development of new updated KQs for patients with inflammatory arthritis., (Copyright © 2019. Published by Elsevier Masson SAS.)- Published
- 2019
- Full Text
- View/download PDF
7. Assessment of the adherence to disease-modifying drugs in patients with chronic inflammatory rheumatic diseases: Results of a survey of 1594 patients.
- Author
-
López-Medina C, Moltó A, Gérald F, Dubremetz M, Grange L, Thibaud G, Charles B, Lafarge D, Beauvais C, Gossec L, and Dougados M
- Subjects
- Antirheumatic Agents therapeutic use, Chronic Disease, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Arthritis, Rheumatoid drug therapy, Biological Products therapeutic use, Medication Adherence, Methotrexate therapeutic use, Surveys and Questionnaires
- Abstract
Objectives: a) to describe the self-reported adherence to disease modifying drugs (DMARDs) (methotrexate and biological DMARDs) among patients with chronic inflammatory rheumatic diseases (CIRDs); b) to assess factors associated with non-adherence., Methods: An observational, cross-sectional, nationwide study was conducted through the use of an electronic survey, which was released via patient organizations in France to rheumatic patients. The main outcome was the rate of non-adherence to DMARDs, which was evaluated with the following question "Have you ever tried to stop or space out your treatment in contrast to what was planned with your doctor?" A positive answer was considered "low adherent". Sociodemographic variables, type of CIRD and treatment information were also collected. Factors associated with low adherence to methotrexate and bDMARDs were explored by univariate and multivariate logistic regressions., Results: Among the 1594 participants who completed the survey, 795 (49.9%) were receiving methotrexate and 709 (44.5%) bDMARDs. A total of 159 (20.0%) were identified as low adherents to methotrexate, and being a woman was independently associated with low adherence (OR 1.90 [95% CI 1.07 - 3.36)] to this drug. Regarding bDMARDs, 177 (25.0%) were identified as low adherent, and the factors independently associated with low adherence were being employed (OR 1.47 [95% CI 1.04 - 2.09]) and no concomitant use of methotrexate (OR 0.51 [95% CI 0.36 - 0.73])., Conclusions: This study suggests that more than 20% of CIRDs patients are low adherent to their DMARDs, and this is more frequent when bDMARDs are administered as a monotherapy., (Copyright © 2019 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
8. Prealbumin, platelet factor 4 and S100A12 combination at baseline predicts good response to TNF alpha inhibitors in rheumatoid arthritis.
- Author
-
Nguyen MVC, Baillet A, Romand X, Trocmé C, Courtier A, Marotte H, Thomas T, Soubrier M, Miossec P, Tébib J, Grange L, Toussaint B, Lequerré T, Vittecoq O, and Gaudin P
- Subjects
- Adult, Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid physiopathology, Biological Products therapeutic use, Biomarkers blood, Cohort Studies, Female, France, Humans, Logistic Models, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Treatment Outcome, Arthritis, Rheumatoid blood, Arthritis, Rheumatoid drug therapy, Platelet Factor 4 blood, Prealbumin metabolism, S100A12 Protein metabolism, Tumor Necrosis Factor Inhibitors therapeutic use
- Abstract
Objectives: Tumour necrosis factor-alpha inhibitors (TNFi) are effective treatments for Rheumatoid Arthritis (RA). Responses to treatment are barely predictable. As these treatments are costly and may induce a number of side effects, we aimed at identifying a panel of protein biomarkers that could be used to predict clinical response to TNFi for RA patients., Methods: Baseline blood levels of C-reactive protein, platelet factor 4, apolipoprotein A1, prealbumin, α1-antitrypsin, haptoglobin, S100A8/A9 and S100A12 proteins in bDMARD naive patients at the time of TNFi treatment initiation were assessed in a multicentric prospective French cohort. Patients fulfilling good EULAR response at 6 months were considered as responders. Logistic regression was used to determine best biomarker set that could predict good clinical response to TNFi., Results: A combination of biomarkers (prealbumin, platelet factor 4 and S100A12) was identified and could predict response to TNFi in RA with sensitivity of 78%, specificity of 77%, positive predictive values (PPV) of 72%, negative predictive values (NPV) of 82%, positive likelihood ratio (LR+) of 3.35 and negative likelihood ratio (LR-) of 0.28. Lower levels of prealbumin and S100A12 and higher level of platelet factor 4 than the determined cutoff at baseline in RA patients are good predictors for response to TNFi treatment globally as well as to Infliximab, Etanercept and Adalimumab individually., Conclusion: A multivariate model combining 3 biomarkers (prealbumin, platelet factor 4 and S100A12) accurately predicted response of RA patients to TNFi and has potential in a daily practice personalized treatment., (Copyright © 2018 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
9. An e-health interactive self-assessment website (Sanoia ® ) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patients.
- Author
-
Gossec L, Cantagrel A, Soubrier M, Berthelot JM, Joubert JM, Combe B, Czarlewski W, Wendling D, Dernis E, Grange L, Beauvais C, Perdriger A, Nataf H, Dougados M, and Servy H
- Subjects
- Female, Follow-Up Studies, Humans, Male, Middle Aged, Patient Satisfaction, Retrospective Studies, Time Factors, Arthritis, Rheumatoid therapy, Physician-Patient Relations, Quality of Health Care, Quality of Life, Self-Assessment, Telemedicine methods
- Abstract
Introduction: Sanoia is an online interactive electronic e-health platform developed to allow patient self-assessment and self-monitoring. The objective was to assess in rheumatoid arthritis (RA) patients, the efficacy on patient-physician interactions, of giving access to Sanoia., Methods: In this French, multi-center, 12-months randomized controlled trial (CarNET: NCT02200068), patients with RA and internet access were randomized to: access without incentives to the Sanoia platform after minimal training, or usual care. The primary outcome was the change from baseline in patient-physician interactions, by the patient-reported Perceived Efficacy in Patient-Physician Interactions (PEPPI-5) questionnaire. The number of accesses to Sanoia was recorded and satisfaction with the platform was assessed through a 0-10 numeric rating scale. Analyses were in intention to treat (ITT), on SAS., Results: Of 320 RA patients (159 Sanoia versus 161 usual care), mean (standard deviation) age was 57.0 (12.7) years, mean (SD) disease duration was 14.6 (11.1) years, 216 (67.5%) were taking a biologic and 253 (79.1%) were female. Mean (SD) PEPPI scores at baseline and 12 months were 38.6 (8.2) and 39.2 (8.0) (delta=+0.60 [5.52]) versus 39.7 (7.3) and 38.8 (8.0) (delta=-0.91 [6.08]) in the Sanoia and control group, respectively (P=0.01). Although mean satisfaction with the platform was very high (1.46 [1.52]), 41 patients (25.7%) never accessed Sanoia., Conclusion: Giving RA patients access to the interactive Sanoia e-health platform led to a small improvement in patient-perceived patient-physician interactions. A disjunction between patient satisfaction and access to the platform was noted. E-Health platforms are promising in RA., (Copyright © 2017 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
10. Differences in MMPs and TIMP-1 expression between intervertebral disc and disc herniation.
- Author
-
Baillet A, Grange L, Trocmé C, Caudroy S, Juvin R, Birembaut P, Morel F, and Gaudin P
- Subjects
- Adult, Female, Humans, Intervertebral Disc Degeneration pathology, Intervertebral Disc Degeneration surgery, Intervertebral Disc Displacement pathology, Intervertebral Disc Displacement surgery, Male, Matrix Metalloproteinases metabolism, Middle Aged, Intervertebral Disc Degeneration metabolism, Intervertebral Disc Displacement metabolism, Matrix Metalloproteinase 3 metabolism, Tissue Inhibitor of Metalloproteinase-1 metabolism
- Published
- 2013
- Full Text
- View/download PDF
11. Can we improve the diagnosis of spondyloarthritis in patients with uncertain diagnosis? The EchoSpA prospective multicenter French cohort.
- Author
-
D'Agostino MA, Saraux A, Chary-Valckenaere I, Marcelli C, Guis S, Gaudin P, Aegerter P, Jousse-Joulin S, Loeuille D, Judet O, Lecoq B, Hacquard-Bouder C, Grange L, Guzian MC, Blum A, Chagnaud C, Leboime A, Monnet D, Rat AC, Timsit MA, Said-Nahal R, and Breban M
- Subjects
- Adolescent, Adult, Aged, Cohort Studies, Female, Follow-Up Studies, France, HLA-B27 Antigen blood, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Sacroiliitis pathology, Sensitivity and Specificity, Spondylarthritis ethnology, Young Adult, Spondylarthritis diagnosis, Spondylarthritis diagnostic imaging, Ultrasonography, Doppler
- Abstract
Unlabelled: Power Doppler ultrasound (PDUS) has proved to be a highly sensitive tool for assessing enthesitis in spondyloarthritis (SpA). In patients with a suspected SpA, diagnosis could be improved by detecting enthesitis with PDUS., Objective: To evaluate the performance of PDUS for the diagnosis of SpA alone or combined with other clinical, laboratory and imaging findings in patients consulting for a suspected SpA., Methods: Prospective, multicenter French cohort study (Boulogne-Billancourt, Brest, Caen, Grenoble, Marseille and Nancy). Outpatients consulting for symptoms suggestive of SpA (inflammatory back pain [IBP], arthritis or inflammatory arthralgia [IA], enthesitis or dactylitis [ED], HLA-B27 positive uveitis [B27+U], familiarity for SpA [Fam]) were recruited and followed up for at least 2 years. Sample size was set to 500 patients (for estimated prevalence of SpA of 30±5% after 2 years). At baseline, patients were submitted to standardized physical examination, pelvic X-ray, sacroiliac joints magnetic resonance imaging (MRI), HLA-B typing, and other tests judged useful for diagnosis. For each patient, a blinded PDUS examination of 14 enthesitic sites was performed at baseline and at years 1 and 2. Patients were planned to be followed during 5 years. The diagnosis of SpA ascertained by an experts' committee, blind to PDUS results, after at least 2 years of follow-up, with a revaluation of doubtful patients at 5 years will be used as gold standard for evaluating the diagnostic performance of PDUS and the best diagnostic procedure by combining PDUS, clinical symptoms and other tests., Results: Between January 2005 and September 2007, 489 patients were included (96% of the target population). Nineteen patients (0.2%) retired their informed consensus or were lost to follow-up immediately after their inclusion. At baseline, mean age of the 470 remaining patients was 40 years, mean duration of symptoms was 6.1 years; 42% of them were HLA-B27+ and 63% were female. Primary inclusion criterion was IBP in 53%, IA in 27%, ED in 9%, B27+U in 8% and Fam in 4%. Follow-up is still ongoing., Conclusion: We have set up a unique diagnostic cohort which includes the entire spectrum of SpA manifestations. By using PDUS we expected to improve the diagnostic procedure of SpA., (Copyright © 2012. Published by Elsevier SAS.)
- Published
- 2012
- Full Text
- View/download PDF
12. Is dynamic exercise beneficial in patients with rheumatoid arthritis?
- Author
-
Gaudin P, Leguen-Guegan S, Allenet B, Baillet A, Grange L, and Juvin R
- Subjects
- Adult, Arthritis, Rheumatoid physiopathology, Humans, Muscle Strength, Muscle Stretching Exercises, Randomized Controlled Trials as Topic, Recovery of Function, Treatment Outcome, Arthritis, Rheumatoid rehabilitation, Exercise Therapy methods
- Abstract
Introduction: Dynamic exercise therapy as defined by the American College of Sports Medicine for healthy individuals is of unclear relevance to patients with rheumatoid arthritis (RA). No recommendations on this issue are available. Few studies have evaluated the optimal program, frequency, or target population; furthermore, there is no consensus about the best assessment tools for monitoring clinical, functional, and structural parameters during dynamic exercise therapy in patients with RA., Methods: We conducted an extensive review of the literature published between 1964 and 2005. We identified nine randomized controlled studies that provided a high level of proof regarding the effects of dynamic exercise therapy in RA patients older than 18 years of age., Results: Dynamic exercise programs improve aerobic capacity and muscle strength in patients with RA. Their effects on functional capacity are unclear, and many sources of bias influenced the study results. The clinical and laboratory safety profiles were good. The structural impact of dynamic exercise remains to be determined.
- Published
- 2008
- Full Text
- View/download PDF
13. Radiculopathy as a manifestation of Langerhans' cell histiocytosis.
- Author
-
Baillet A, Grange L, Lafaix PA, Gaudin P, and Juvin R
- Subjects
- Acetabulum innervation, Adult, Female, Femur innervation, Histiocytosis, Langerhans-Cell diagnosis, Histiocytosis, Langerhans-Cell therapy, Humans, Lumbosacral Region, Male, Radiculopathy diagnosis, Radiculopathy therapy, Sciatica etiology, Treatment Outcome, Histiocytosis, Langerhans-Cell complications, Radiculopathy etiology
- Abstract
Langerhans' cell histiocytosis (LCH) is a rare condition of children and young adults in which Langerhans' cells proliferate. The clinical spectrum ranges from solitary or few focal lesions to multisystem involvement mimicking vasculitis or hematological malignancy. Focal bone lesions, known as eosinophilic granulomas, are the most common manifestations. Eosinophilic granuloma usually presents with a variable combination of pain, swelling, fracture, and fever. Facial bone involvement may manifest as an ear discharge, hearing loss, or exophthalmos. Nerve root pain is rarely reported, even in patients with lesions in the axial skeleton. We report four cases of nerve root pain caused by LCH. Two male patients aged 25 and 34 years, respectively, presented with truncated femoral neuralgia related to acetabular granulomas. A 25-year-old woman with involvement of the L5 vertebral body and a 41-year-old man with a sacral lesion presented with sciatica.
- Published
- 2007
- Full Text
- View/download PDF
14. Pyogenic discitis revealing infrarenal aortic prosthetic graft infection impinging on the left ureter.
- Author
-
Dreyfus J, Grange L, Sessa C, and Juvin R
- Subjects
- Aged, Aortic Aneurysm, Abdominal surgery, Carrier Proteins blood, Humans, Male, Blood Vessel Prosthesis adverse effects, Discitis complications, Prosthesis-Related Infections complications
- Abstract
Coexistence of aortic lesions and discitis is uncommon but potentially fatal if the diagnosis is not made promptly. We report the case of a 71-year-old patient with an infected prosthetic graft of the abdominal aorta impinging on the left ureter and accompanied with lumbar discitis. This triad has not been reported previously. Other unusual features in this patient were the circumstances of onset and the development of the infection in a vascular prosthetic graft. The medical and surgical treatment is discussed.
- Published
- 2003
- Full Text
- View/download PDF
15. Extensive primary epidural abscess. Report of a case.
- Author
-
Duc C, Grange L, Gaudin P, Brun F, Terki RK, Barbier LP, Phelip X, and Juvin R
- Subjects
- Aged, Atrophy, Female, Humans, Magnetic Resonance Imaging, Spinal Cord pathology, Epidural Abscess microbiology, Epidural Abscess pathology, Staphylococcal Infections pathology
- Abstract
We report a case of Staphylococcus aureus epidural infection extending from the cervical to the lumbar spine. Findings from the first magnetic resonance imaging study were misleading. The symptoms resolved fully under medical treatment, with no recurrence after 1 year.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.